Dodd Cathy 4

4 · AVIENT CORP · Filed May 7, 2021

Form 4

Period: 2021-05-05

SVP, Chief Commercial Officer

Transactions

Disposition to Issuer
Common Stock
2021-05-05$53.19/sh−1,777$94,519→ 10,541 total
Sale
Common Stock
2021-05-05$53.13/sh−253.877$13,488→ 0 total(indirect: By Spouse)
Sale
Common Stock
2021-05-06$53.00/sh−2,073$109,869→ 10,018 total
Exercise/Conversion
Stock Appreciation Rights
2021-05-05−2,300→ 0 total
Exercise: $36.04Exp: 2024-02-17→ Common Stock (2,300 underlying)
Exercise/Conversion
Common Stock
2021-05-05$36.04/sh+2,300$82,892→ 12,318 total
Exercise/Conversion
Common Stock
2021-05-05$24.98/sh+4,140$103,417→ 14,681 total
Disposition to Issuer
Common Stock
2021-05-05$53.19/sh−2,590$137,762→ 12,091 total
Exercise/Conversion
Stock Appreciation Rights
2021-05-05−4,140→ 0 total
Exercise: $24.98Exp: 2026-02-10→ Common Stock (4,140 underlying)

Holdings

Footnotes (4)

[F1]Includes shares acquired pursuant to dividend reinvestment.
[F2]The information in this report is based on a Avient Retirement Savings Plan statement as of April 30, 2021.
[F3]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $36.04 per share and no more than one-third of the grant can vest per year during the first three years.
[F4]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.

Documents

1 file